|
1
|
Siegel RL, Giaquinto AN and Jemal A:
Cancer statistics, 2024. CA Cancer J Clin. 74:12–49. 2024.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bahadoram S, Davoodi M, Hassanzadeh S,
Bahadoram M, Barahman M and Mafakher L: Renal cell carcinoma: An
overview of the epidemiology, diagnosis, and treatment. G Ital
Nefrol. 3:392022.
|
|
3
|
Mori K, Mostafaei H, Miura N, Karakiewicz
PI, Luzzago S, Schmidinger M, Bruchbacher A, Pradere B, Egawa S and
Shariat SF: Systemic therapy for metastatic renal cell carcinoma in
the first-line setting: A systematic review and network
meta-analysis. Cancer Immunol Immunother. 70:265–273. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wein A, Kavoussi L, Partin A and Peters C:
Campbell-Walsh urology: 4-Volume Set. (11th Ed.). Fac Bookshelf;
Elsevier, Philadelphia, PA: 2016
|
|
5
|
Liu X, Hao Y, Yu W, Yang X, Luo X, Zhao J,
Li J, Hu X and Li L: Long non-coding RNA emergence during renal
cell carcinoma tumorigenesis. Cell Physiol Biochem. 47:735–746.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gilbert N: Surgical treatment of pulmonary
metastases in metastatic renal cell carcinoma. Aktuelle Urol.
51:271–274. 2020.(In German). PubMed/NCBI
|
|
7
|
Bosma NA, Warkentin MT, Gan CL, Karim S,
Heng DYC, Brenner DR and Lee-Ying RM: Efficacy and safety of
first-line systemic therapy for metastatic renal cell carcinoma: A
systematic review and network meta-analysis. Eur Urol Open Sci.
37:14–26. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Djebali S, Davis CA, Merkel A, Dobin A,
Lassmann T, Mortazavi A, Tanzer A, Lagarde J, Lin W, Schlesinger F,
et al: Landscape of transcription in human cells. Nature.
489:101–108. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Martens-Uzunova ES, Böttcher R, Croce CM,
Jenster G, Visakorpi T and Calin GA: Long noncoding RNA in
prostate, bladder, and kidney cancer. Eur Urol. 65:1140–1151. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ponting CP, Oliver PL and Reik W:
Evolution and functions of long noncoding RNAs. Cell. 136:629–641.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Shi X, Sun M, Liu H, Yao Y and Song Y:
Long non-coding RNAs: A new frontier in the study of human
diseases. Cancer Lett. 339:159–166. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wapinski O and Chang HY: Long noncoding
RNAs and human disease. Trends Cell Biol. 21:354–361. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gao N, Li Y, Li J, Gao Z, Yang Z, Li Y,
Liu H and Fan T: Long non-coding RNAs: The regulatory mechanisms,
research strategies, and future directions in cancers. Front Oncol.
10:5988172020. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bhan A, Soleimani M and Mandal SS: Long
noncoding RNA and cancer: A new paradigm. Cancer Res. 77:3965–3981.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhou S, Wang J and Zhang Z: An emerging
understanding of long noncoding RNAs in kidney cancer. J Cancer Res
Clin Oncol. 140:1989–1995. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Braga EA, Fridman MV, Filippova EA,
Loginov VI, Pronina IV, Burdennyy AM, Karpukhin AV, Dmitriev AA and
Morozov SG: LncRNAs in the regulation of genes and signaling
pathways through miRNA-mediated and other mechanisms in clear cell
renal cell carcinoma. Int J Mol Sci. 22:111932021. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Pi YN, Qi WC, Xia BR, Lou G and Jin WL:
Long non-coding RNAs in the tumor immune microenvironment:
Biological properties and therapeutic potential. Front Immunol.
12:6970832021. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xu P, Feng D, Wang J, Wang YD, Xie G,
Zhang B, Li XH, Zeng JW and Feng JF: LncRNA AGAP2 antisense RNA 1
stabilized by insulin-like growth factor 2 mRNA binding protein 3
promotes macrophage M2 polarization in clear cell renal cell
carcinoma through regulation of the microRNA-9-5p/THBS2/PI3K-Akt
pathway. Cancer Cell Int. 23:3302023. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gao Y, Wang X, Dong L, Qu C, Lu Q, Wang P,
Xin M, Zheng W, Liu C and Ning S: Identifying immune
checkpoint-related lncRNA biomarkers for immunotherapy response and
prognosis in cancers. Sci Data. 10:6632023. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Qiao HP, Gao WS, Huo JX and Yang ZS: Long
non-coding RNA GAS5 functions as a tumor suppressor in renal cell
carcinoma. Asian Pac J Cancer Prev. 14:1077–1082. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kawakami T, Chano T, Minami K, Okabe H,
Okada Y and Okamoto K: Imprinted DLK1 is a putative tumor
suppressor gene and inactivated by epimutation at the region
upstream of GTL2 in human renal cell carcinoma. Hum Mol Genet.
15:821–830. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bertozzi D, Iurlaro R, Sordet O, Marinello
J, Zaffaroni N and Capranico G: Characterization of novel antisense
HIF-1α transcripts in human cancers. Cell Cycle. 10:3189–3197.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Frevel MA, Sowerby SJ, Petersen GB and
Reeve AE: Methylation sequencing analysis refines the region of H19
epimutation in Wilms tumor. J Biol Chem. 274:29331–29340. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chiesa N, De Crescenzo A, Mishra K, Perone
L, Carella M, Palumbo O, Mussa A, Sparago A, Cerrato F, Russo S, et
al: The KCNQ1OT1 imprinting control region and non-coding RNA: New
properties derived from the study of Beckwith-Wiedemann syndrome
and Silver-Russell syndrome cases. Hum Mol Genet. 21:10–25. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Davis IJ, Hsi BL, Arroyo JD, Vargas SO,
Yeh YA, Motyckova G, Valencia P, Perez-Atayde AR, Argani P, Ladanyi
M, et al: Cloning of an Alpha-TFEB fusion in renal tumors harboring
the t(6;11)(p21;q13) chromosome translocation. Proc Natl Acad Sci
USA. 100:6051–6056. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kuiper RP, Schepens M, Thijssen J, van
Asseldonk M, van den Berg E, Bridge J, Schuuring E, Schoenmakers EF
and van Kessel AG: Upregulation of the transcription factor TFEB in
t(6;11)(p21;q13)-positive renal cell carcinomas due to promoter
substitution. Hum Mol Genet. 12:1661–1669. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chiyomaru T, Fukuhara S, Saini S, Majid S,
Deng G, Shahryari V, Chang I, Tanaka Y, Enokida H, Nakagawa M, et
al: Long non-coding RNA HOTAIR is targeted and regulated by miR-141
in human cancer cells. J Biol Chem. 289:12550–12565. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Jeong G, Kwon DH, Shin S, Choe N, Ryu J,
Lim YH, Kim J, Park WJ, Kook H and Kim YK: Long noncoding RNAs in
vascular smooth muscle cells regulate vascular calcification. Sci
Rep. 9:58482019. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chen J, Lan J, Ye Z, Duan S, Hu Y, Zou Y
and Zhou J: Long noncoding RNA LRRC75A-AS1 inhibits cell
proliferation and migration in colorectal carcinoma. Exp Biol Med
(Maywood). 244:1137–1143. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Han L, Li Z, Jiang Y, Jiang Z and Tang L:
SNHG29 regulates miR-223-3p/CTNND1 axis to promote glioblastoma
progression via Wnt/β-catenin signaling pathway. Cancer Cell Int.
19:3452019. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Li S, Wu D, Jia H and Zhang Z: Long
non-coding RNA LRRC75A-AS1 facilitates triple negative breast
cancer cell proliferation and invasion via functioning as a ceRNA
to modulate BAALC. Cell Death Dis. 11:6432020. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wang X, Wang H, Zhang R, Li D and Gao MQ:
LRRC75A antisense lncRNA1 knockout attenuates inflammatory
responses of bovine mammary epithelial cells. Int J Biol Sci.
16:251–263. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Enright AJ, John B, Gaul U, Tuschl T,
Sander C and Marks DS: MicroRNA targets in Drosophila. Genome Biol.
5:R12003. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kozomara A, Birgaoanu M and
Griffiths-Jones S: miRBase: From microRNA sequences to function.
Nucleic Acids Res. 47:D155–D162. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Xie Q, Qin F, Luo L, Deng S, Zeng K, Wu Y,
Liao D, Luo L and Wang K: hsa_circ_0003596, as a novel oncogene,
regulates the malignant behavior of renal cell carcinoma by
modulating glycolysis. Eur J Med Res. 28:3152023. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Fuhrman SA, Lasky LC and Limas C:
Prognostic significance of morphologic parameters in renal cell
carcinoma. Am J Surg Pathol. 6:655–663. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Amin MB, Greene FL, Edge SB, Compton CC,
Gershenwald JE, Brookland RK, Meyer L, Gress DM, Byrd DR and
Winchester DP: The eighth edition AJCC cancer staging manual:
Continuing to build a bridge from a population-based to a more
‘personalized’ approach to cancer staging. CA Cancer J Clin.
67:93–99. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Huang T, Alvarez A, Hu B and Cheng SY:
Noncoding RNAs in cancer and cancer stem cells. Chin J Cancer.
32:582–593. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Fang Y and Fullwood MJ: Roles, functions,
and mechanisms of long non-coding RNAs in cancer. Genomics
Proteomics Bioinformatics. 14:42–54. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Pan Y, Lu X, Shu G, Cen J, Lu J, Zhou M,
Huang K, Dong J, Li J, Lin H, et al: Extracellular vesicle-mediated
transfer of LncRNA IGFL2-AS1 confers sunitinib resistance in renal
cell carcinoma. Cancer Res. 83:103–116. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Dykes IM and Emanueli C: Transcriptional
and post-transcriptional gene regulation by long non-coding RNA.
Genomics Proteomics Bioinformatics. 15:177–186. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Li C, Ge Q, Liu J, Zhang Q, Wang C, Cui K
and Chen Z: Effects of miR-1236-3p and miR-370-5p on activation of
p21 in various tumors and its inhibition on the growth of lung
cancer cells. Tumor Biol. 39:10104283177108242017. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Zhang Y, Li L, Lu KX, Yu LB, Meng J and
Liu CY: LncRNA SNHG3 is responsible for the deterioration of
colorectal carcinoma through regulating the miR-370-5p/EZH1 axis.
Eur Rev Med Pharmacol Sci. 25:6131–6137. 2021.PubMed/NCBI
|
|
45
|
Zhou Z, Xu F and Zhang T: Circular RNA
COL1A1 promotes Warburg effect and tumor growth in nasopharyngeal
carcinoma. Discov Oncol. 15:1202024. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Mochizuki S and Okada Y: ADAMs in cancer
cell proliferation and progression. Cancer Sci. 98:621–628. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Zhu Z, Xu J, Wu X, Lin S, Li L, Ye W and
Huang Z: In silico identification of contradictory role of ADAMTS5
in hepatocellular carcinoma. Technol Cancer Res Treat.
20:15330338209868262021. View Article : Google Scholar : PubMed/NCBI
|
